Literature DB >> 12475634

Epidemiology of visceral leishmaniasis in Atbara River area, eastern Sudan: the outbreak of Barbar El Fugara village (1996-1997).

Sayda Hassan EL-Safi1, Bruno Bucheton, Musa Mohamed Kheir, Hassan Abdel Aziz Musa, Moawia EL-Obaid, Awad Hammad, Alain Dessein.   

Abstract

An outbreak of visceral leishmaniasis (VL) started in 1995 in the Atbara River area in eastern Sudan. This article reports on this outbreak and on the clinical and immunological studies that were carried out in a village, with the highest incidence of VL cases, from 1996 to 1997. A significant increase in VL incidence was recorded in a dozen villages in this area; one village, Barbar El Fugara accounted for half of the total number of cases recorded at the regional hospital. A total of 152 VL and 61 post kala-azar dermal lesion (PKDL) cases were diagnosed and treated in Barbar. Household (n = 671) and school (n = 276) surveys were performed using the leishmanin skin test (LST) and the direct agglutination test (DAT). LST positivity was 23.1 and 15.7%, whereas DAT positivity was 8.9 and 26.4% in both surveys, respectively. No gender differences were observed in either test. Unlike DAT, LST positivity was predominant in the higher age groups that also exhibited lower prevalence of VL. Few individuals were positive by both tests (1.3%, 5.2%) while the majority (68.8%, 64.8%) had no evidence of acquired immune response, suggesting either a role of innate immunity in preventing parasite establishment or, unexpectedly, lack of exposure to Leishmania. Subclinical parasitism was also demonstrated, as evidence of both acquired humoral and cellular immune responses was observed in individuals with no past history of the disease. The wide spectrum of L. donovani/human interactions may be explained by differential exposure to environmental risk factors, parasite strain polymorphisms or host genetic makeup.

Entities:  

Mesh:

Year:  2002        PMID: 12475634     DOI: 10.1016/s1286-4579(02)00026-6

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  12 in total

1.  IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani.

Authors:  Maira G R Pitta; Audrey Romano; Sandrine Cabantous; Sandrine Henri; Awad Hammad; Bouréma Kouriba; Laurent Argiro; Musa el Kheir; Bruno Bucheton; Charles Mary; Sayda Hassan El-Safi; Alain Dessein
Journal:  J Clin Invest       Date:  2009-07-13       Impact factor: 14.808

2.  Usefulness of the rK39-immunochromatographic test, direct agglutination test, and leishmanin skin test for detecting asymptomatic Leishmania infection in children in a new visceral leishmaniasis focus in Amhara State, Ethiopia.

Authors:  Endalamaw Gadisa; Estefanía Custodio; Carmen Cañavate; Luis Sordo; Zelalem Abebe; Javier Nieto; Carmen Chicharro; Abraham Aseffa; Lawrence Yamuah; Howard Engers; Javier Moreno; Israel Cruz
Journal:  Am J Trop Med Hyg       Date:  2012-05       Impact factor: 2.345

3.  A major susceptibility locus on chromosome 22q12 plays a critical role in the control of kala-azar.

Authors:  Bruno Bucheton; Laurent Abel; Sayda El-Safi; Musa M Kheir; Sylvana Pavek; Arnaud Lemainque; Alain J Dessein
Journal:  Am J Hum Genet       Date:  2003-10-13       Impact factor: 11.025

Review 4.  Genetic studies of African populations: an overview on disease susceptibility and response to vaccines and therapeutics.

Authors:  Giorgio Sirugo; Branwen J Hennig; Adebowale A Adeyemo; Alice Matimba; Melanie J Newport; Muntaser E Ibrahim; Kelli K Ryckman; Alessandra Tacconelli; Renato Mariani-Costantini; Giuseppe Novelli; Himla Soodyall; Charles N Rotimi; Raj S Ramesar; Sarah A Tishkoff; Scott M Williams
Journal:  Hum Genet       Date:  2008-05-30       Impact factor: 4.132

Review 5.  Visceral leishmaniasis: new health tools are needed.

Authors:  Asrat Hailu; Ahmed Mudawi Musa; Catherine Royce; Monique Wasunna
Journal:  PLoS Med       Date:  2005-07-26       Impact factor: 11.069

6.  Prevalence of asymptomatic Leishmania infection and associated risk factors, after an outbreak in the south-western Madrid region, Spain, 2015.

Authors:  Ana Victoria Ibarra-Meneses; Eugenia Carrillo; Javier Nieto; Carmen Sánchez; Sheila Ortega; Alicia Estirado; Pello Latasa Zamalloa; Juan Carlos Sanz; Luis García-Comas; María Ordobás; Javier Moreno
Journal:  Euro Surveill       Date:  2019-05

7.  Concomitant malaria among visceral leishmaniasis in-patients from Gedarif and Sennar States, Sudan: a retrospective case-control study.

Authors:  Erika van den Bogaart; Marieke M Z Berkhout; Ayman B Y M Nour; Pètra F Mens; Al-Badawi A Talha; Emily R Adams; Hashim B M Ahmed; Samira H Abdelrahman; Koert Ritmeijer; Bakri Y M Nour; Henk D F H Schallig
Journal:  BMC Public Health       Date:  2013-04-11       Impact factor: 3.295

8.  Epidemiology and clinical features of patients with visceral leishmaniasis treated by an MSF clinic in Bakool region, Somalia, 2004-2006.

Authors:  Marie-Eve Raguenaud; Anna Jansson; Veerle Vanlerberghe; Geert Van der Auwera; Stijn Deborggraeve; Jean-Claude Dujardin; Giannos Orfanos; Tony Reid; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2007-10-31

9.  Case Report: Visceral Leishmaniasis with Salmonella Paratyphi and Brucella melitensis Coinfection as a Cause of Persistent Fever in a Patient from Sudan.

Authors:  Sayda El Safi; Hussam Elshikh; Enaam El Sanousi; Nagwa El Amin; Alfarazdag Mohammed; Kristien Verdonck; Jan Jacobs; Marleen Boelaert; François Chappuis
Journal:  Am J Trop Med Hyg       Date:  2018-11       Impact factor: 2.345

10.  Analysis of genetic polymorphisms and tropism in East African Leishmania donovani by Amplified Fragment Length Polymorphism and kDNA minicircle sequencing.

Authors:  Hanan T Jaber; Asrat Hailu; Francine Pratlong; Patrick Lami; Patrick Bastien; Charles L Jaffe
Journal:  Infect Genet Evol       Date:  2018-07-19       Impact factor: 3.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.